Pharmacy Technician Certification Board Relaunches Online Testing Delivery for Certified Pharmacy Technicians

Published on :

The Pharmacy Technician Certification Board (PTCB) is kicking off 2023 with new opportunities for Certified Pharmacy Technicians (CPhTs) to demonstrate their knowledge and earn advanced and specialty certificates. PTCB is relaunching OnVUE, an online proctored testing platform, allowing PTCB CPhTs to earn advanced credentials more conveniently.

TEDCO Partners with The Maryland Department of Commerce to Expand DefTech

Published on :

TEDCO, Maryland’s economic engine for technology companies, announced today its partnership with the Maryland Department of Commerce (Maryland Commerce) to expand and enhance the Maryland Defense Technology Commercialization (DefTech) Center. DefTech supports the growth of businesses by helping them leverage the technology, facilities and expertise in the Maryland Department of Defense (DoD) labs.

New TEDCO Study Outlines Critical Steps Needed to Cultivate a Thriving, Inclusive and Growing Innovation Economy

TEDCO logo over a backdrop of the Maryland flag
Published on :

TEDCO, Maryland’s economic engine for technology companies, unveiled a legislatively mandated Maryland Innovation Competitiveness Study—one that could lead to a 5-year, $250 million down payment for an Equitech Growth Fund and the establishment of a major Kirwan-type commission. The new commission would map out an in-depth strategic plan focused on ensuring Maryland becomes a national model for a thriving, inclusive tech sector and innovation economy.

CRB Encourages Life Sciences Companies to Take Advantage of Sustainability Incentives

Published on :

Sustainability is more than just a buzzword these days: it’s a core part of companies’ mission statements and workplace culture. As the climate change crisis continues to worsen, local, state, and federal governments have started offering incentives for companies to incorporate sustainability into their buildings and practices. And many companies have been doing so. 

BioHealth Capital Region Eyes Continued Growth in 2023, Charts New Goals Amidst Tough Economic Headwinds

Published on :

That’s the assessment of Rich Bendis, President and Chief Executive Officer of BHI, who has championed the region’s transition into a top four biopharma hub in the United States. However, given the state of the economy and the amount of money being invested, Bendis said it is unrealistic to expect the region to move up the ranking of the top 10 life sciences regions compiled by Genetic Engineering & Biotechnology News (GEN).

Novavax Names John C. Jacobs as New President & Chief Executive Officer

Published on :

Novavax Names John C. Jacobs as New President & Chief Executive Officer
Jan 9, 2023
Current President & CEO Stanley C. Erck will retire effective January 23 with plans to support the leadership transition in an advisory capacity
Novavax is well-positioned to execute on its strategy, with global authorizations for its COVID-19 vaccine and continued clinical pipeline development
GAITHERSBURG, Md., Jan. 9, 2023 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that John C. Jacobs will succeed Stanley C. Erck as President and Chief Executive Officer and a member of the Board of Directors. The transition will be effective as of January 23, 2023. Mr. Erck will serve as an advisor to the Company for the next fifteen months to enable a smooth transition.
“As we prepare for Stan’s retirement, the Board reflects on the incredible legacy he leaves behind,” said James F. Young, PhD, Chairman of the Board of Directors. “Stan led Novavax from a clinical development organization to a global commercial vaccines company during a worldwide pandemic. This foundation puts Novavax in a strong position to execute on its long-term strategy, and we look…

Medcura Receives Breakthrough Device Designation for its LifeGel™ Absorbable Surgical Hemostat

Published on :

Medcura, Inc., a medical device company dedicated to transformatively improving the management of surgical bleeding, announces that the U.S. Food and Drug Administration (FDA) has granted the coveted Breakthrough Device Designation for its LifeGel™ Absorbable Surgical Hemostat. LifeGel™ is the first and only hemostatic agent to receive Breakthrough Device Designation seeking a new and highly differentiated indication: in surgical procedures (except in ophthalmic and urological) as an adjunctive hemostatic device when control of minimal, mild, and moderate bleeding by conventional procedures is ineffective or impractical. Due to its no-swell properties, LifeGel can be used in surgical procedures where swelling cannot be tolerated.

Kite to Add 100 New Jobs in Frederick County With Expansion of Cell Therapy Manufacturing Operations

Published on :

Kite, a Gilead Company, announced plans to expand its global cell therapy supply chain operations in Frederick County, Maryland. This year, the California-based company will begin construction on an approximately 70,000 square-foot centralized raw materials warehouse that will serve Kite’s global manufacturing network and will be located adjacent to its existing facility in the Urbana Corporate Center. The expansion will bring an additional 100 jobs to the area, with the company expecting to employ more than 500 full-time staff between its two facilities by the end of 2026.

McBee Moore & Vanik IP Celebrates Seven Years, Continues Growth

Published on :

McBee, Moore & Vanik IP, LLC began in 2016 when partners Susan McBee, C.G. Moore, David Vanik and 12 employees came together to form a new patent law firm with improved client service as the ultimate goal. This year, the firm is celebrating seven years together.